[go: up one dir, main page]

FI960308L - Förfarande för expression och rening av P2-protein från Haemophilus influenzae, typ b - Google Patents

Förfarande för expression och rening av P2-protein från Haemophilus influenzae, typ b Download PDF

Info

Publication number
FI960308L
FI960308L FI960308A FI960308A FI960308L FI 960308 L FI960308 L FI 960308L FI 960308 A FI960308 A FI 960308A FI 960308 A FI960308 A FI 960308A FI 960308 L FI960308 L FI 960308L
Authority
FI
Finland
Prior art keywords
purifying
expressing
proteins
haemophilus influenzae
influenzae type
Prior art date
Application number
FI960308A
Other languages
English (en)
Finnish (fi)
Other versions
FI960308A0 (sv
Inventor
Joseph Y Tai
Jeffrey K Pullen
Thomas S Soper
Shu-Mei Liang
Original Assignee
North American Vaccine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North American Vaccine Inc filed Critical North American Vaccine Inc
Publication of FI960308A0 publication Critical patent/FI960308A0/sv
Publication of FI960308L publication Critical patent/FI960308L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10211—Podoviridae
    • C12N2795/10222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI960308A 1993-07-23 1996-01-23 Förfarande för expression och rening av P2-protein från Haemophilus influenzae, typ b FI960308L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/096,181 US6153406A (en) 1993-07-23 1993-07-23 Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B
PCT/US1994/008326 WO1995003069A1 (en) 1993-07-23 1994-07-22 Method for expression and purification of p2 protein from haemophilus influenzae type b

Publications (2)

Publication Number Publication Date
FI960308A0 FI960308A0 (sv) 1996-01-23
FI960308L true FI960308L (sv) 1996-03-22

Family

ID=22256123

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960308A FI960308L (sv) 1993-07-23 1996-01-23 Förfarande för expression och rening av P2-protein från Haemophilus influenzae, typ b

Country Status (11)

Country Link
US (1) US6153406A (sv)
EP (1) EP0724455A4 (sv)
JP (1) JPH09500537A (sv)
AU (1) AU698458B2 (sv)
BR (1) BR9407144A (sv)
CA (1) CA2167808A1 (sv)
FI (1) FI960308L (sv)
NO (1) NO960255L (sv)
NZ (1) NZ271500A (sv)
PL (1) PL181695B1 (sv)
WO (1) WO1995003069A1 (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
US6033877A (en) * 1995-11-02 2000-03-07 Research Foundation Of State University Of New York Peptide expression and delivery system
FR2748476B1 (fr) * 1996-05-07 1998-08-14 Pf Medicament Complexe immunogene, son utilisation, son procede de preparation et vaccin le contenant
US6451317B1 (en) 1997-07-17 2002-09-17 Baxter International Inc. Immunogenic conjugates comprising a Group B meningococcal porin and an H influenzae polysaccharide
US7785609B1 (en) 1999-03-16 2010-08-31 Sanofi Pasteur Limited Recombinant Haemophilus influenzae adhesin proteins
DE19939246A1 (de) 1999-08-19 2001-02-22 Phasys Gmbh M Rückfaltung von Membranproteinen
CA2404226A1 (en) * 2000-03-23 2001-09-27 Takeda Chemical Industries, Ltd. Furoisoquinoline derivatives, process for producing the same and use thereof
FR2801219A1 (fr) * 2000-09-18 2001-05-25 Pf Medicament Procede de preparation de proteine recombinante renaturee en presence de detergent
MX2011006903A (es) * 2008-12-25 2011-09-15 Chemo Sero Therapeut Res Inst Vacuna recombinante de coriza infecciosa aviar y procedimiento para preparar la misma.
GB201009861D0 (en) * 2010-06-11 2010-07-21 Novartis Ag OMV vaccines

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4455296A (en) * 1982-02-02 1984-06-19 Board Of Regents, The University Of Texas System Hybrid cell lines producing monoclonal antibodies directed against Haemophilus influenzae
US4459286A (en) * 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
US4695624A (en) * 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4656255A (en) * 1985-09-09 1987-04-07 International Minerals & Chemical Corp. Protein recovery
US5173294A (en) * 1986-11-18 1992-12-22 Research Foundation Of State University Of New York Dna probe for the identification of haemophilus influenzae
US5196338A (en) * 1986-12-31 1993-03-23 Praxis Biologics, Inc. Recombinant vectors for Haemophilus influenzae peptides and proteins
AU623353B2 (en) * 1987-12-10 1992-05-14 Board Of Regents, The University Of Texas System Methods and compositions for the production of haemophilus influenzae type b major outer membrane protein antigens
US5192540A (en) * 1988-04-19 1993-03-09 American Cyanamid Company Haemophilus influenzae type b oxidized polysaccharide-outer membrane protein conjugate vaccine
WO1990006696A2 (en) * 1988-12-19 1990-06-28 Praxis Biologics, Inc. Meningococcal class 1 outer-membrane protein vaccine
CA2006587C (en) * 1988-12-23 2000-01-18 Robert W. Tolan Membrane proteins and peptides of haemophilus influenzae type b
GB8830124D0 (en) * 1988-12-23 1989-02-22 Connaught Lab Membrane proteins and peptides of haemophilus influenzae b
GB8912330D0 (en) * 1989-05-30 1989-07-12 Wellcome Found Live vaccines
DE69019164T2 (de) * 1989-12-14 1995-09-07 National Research Council Of Canada, Ottawa, Ontario Verbessertes meningokokkale polysaccharidkonjugatvakzin.
SE466259B (sv) * 1990-05-31 1992-01-20 Arne Forsgren Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
FI903414A (fi) * 1990-07-06 1992-01-07 Kansanterveyslaitos Produktion av proteiner i grampositiva bakterier.
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5503992A (en) * 1993-09-07 1996-04-02 Washington University DNA encoding the 15kD outer membrane protein of Haemophilus influenzae
US5866135A (en) * 1994-04-21 1999-02-02 North American Vaccine, Inc. Group A streptococcal polysaccharide immunogenic compositions and methods
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis

Also Published As

Publication number Publication date
EP0724455A1 (en) 1996-08-07
WO1995003069A1 (en) 1995-02-02
JPH09500537A (ja) 1997-01-21
EP0724455A4 (en) 1998-02-04
NZ271500A (en) 1997-11-24
PL312700A1 (en) 1996-05-13
BR9407144A (pt) 1996-09-17
PL181695B1 (pl) 2001-09-28
FI960308A0 (sv) 1996-01-23
AU698458B2 (en) 1998-10-29
NO960255D0 (no) 1996-01-22
CA2167808A1 (en) 1995-02-02
NO960255L (no) 1996-03-22
US6153406A (en) 2000-11-28
AU7514494A (en) 1995-02-20

Similar Documents

Publication Publication Date Title
FI973402L (sv) Nya proteiner och förfaranden för producering av proteinerna
FI953883A0 (sv) Förfarande för avskiljning och rening av mjölksyra
FI954423L (sv) Förfarande för rening av taxoider
FI942419L (sv) Förfarande för framställning och rengöring av alfa-interferon
EP0656954A4 (en) PRODUCTION METHOD OF MARKED GENES; TRANSCRIPTS AND PROTEINS.
DE69707849D1 (de) Verfahren zur reinigung von 1,4-butandiol
HK1012398A1 (en) Phosphonomonoester nucleic acids, methods for their preparation and their use
FI962344A (sv) System och förfarande för insprutning av cellulosa
GB8901469D0 (en) Proteins and method for their production
FI962677L (sv) Förfarande och arrangemang för att avlägsna hår
AU6779994A (en) Method and system for protein modeling
IL91500A0 (en) Protein of paramyxovirus,method for the production thereof and vaccine containing the same
FI962247L (sv) Nya apoptosmodulerande proteiner, DNA vilket kodar dessa proteiner samt förfarande för användning av dessa
TR199802394A3 (tr) Proteinleri stabilize etmek için gelistirilmis proses.
FI960308L (sv) Förfarande för expression och rening av P2-protein från Haemophilus influenzae, typ b
HUT58107A (en) Process for producing heparing-binding proteins, dna encoding them and pharmaceutical compositions comprising the proteins
FI19992038L (sv) Förfarande för framställning av azepinoner
FI980853A0 (sv) Ny DNA och förfarande för framställning av protein genom att använda DNA
FI971100L (sv) Förfarande för framställning av rekombinant-DNA-proteiner, plasmider och modifierade celler
FI972186L (sv) Förfarande för framställning av isomaltulos och andra produkter
DE58900795D1 (de) Verfahren und system zum einstellen des lambda-wertes.
FI972314L (sv) Förfarande för framställning av kaprolaktam
HUT68522A (en) Antimicrobial proteins, preparations containing these proteins, and method for production of them
NO960766D0 (no) Nytt protein og fremgangsmåte for fremstilling av dette
GB9005900D0 (en) Process for purifying proteins

Legal Events

Date Code Title Description
FD Application lapsed

Free format text: SANDVIK INTELLECTUAL PROPERTY HANDELSBOLAG